Samuel Le Sourd

35PUBLICATIONS
145CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jul 13, 2026
A Randomized, Nivolumab-controlled, Phase 2 and Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus.

|Jun 30, 2026
Circulating tumour DNA in patients with colorectal cancer undergoing curative-intent LIver MEtastases Surgery in France: a prospective, multicentre GERCOR G-118 CLIMES PRODIGE 77 cohort study protocol.

|Apr 14, 2026
Efficacy of Perioperative Pembrolizumab in Mismatch Repair Deficient/Microsatellite Unstable Localized Colorectal Cancers: Results of the Phase II Trial IMHOTEP.

Christelle de la Fouchardière, Aziz Zaanan, Aymeric de Montfort

|Mar 26, 2026
Toxicity of Capecitabine and Oxaliplatin as Adjuvant Therapy for Stage III Colorectal Cancer Patients With Diverting Stoma.

Andrea Marques, Julie Henriques, Dewi Vernerey

|Dec 29, 2025
Organ-sparing strategies in patients with MSI/dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision-making.

Martin Duval, Antoine Dardenne, Thomas Samaille

|Oct 30, 2025
Efficacy of immunotherapy in gastrointestinal (GI) tumors with mismatch repair deficient (MMRd) unusual phenotype: an AGEO real-world study.

Emily Alouani, Julien Taieb, David Tougeron

Pageof 6

Frequent Collaborators

21 joint publications

Thierry André

9 joint publications

David Tougeron

7 joint publications

Christelle de la Fouchardière

7 joint publications

Julien Taieb